New Research Group BraINE Launched to Advance Brain Imaging and Neuroepidemiology

• Department of Cancer Research
• Department of Precision Health
• Brain Imaging & Neuro Epidemiology

The LIH has launched a new research group, Brain Imaging & Neuro Epidemiology (BraINE), effective January 1, 2025. This new initiative brings together expertise from two existing teams—the Translational Radiomics group, formerly led by Dr. Olivier Keunen, and the Neuro Imaging group, led by Dr. Magali Perquin.

The BraINE group aims to enhance research on brain health and disease through clinical and experimental neuroimaging, advanced analytical methods, and neuroepidemiology. Key focus areas include neuro-oncology, neurodegenerative diseases and neuroscience.

Dr. Olivier Keunen will lead the newly established group with Dr. Magali Perquin serving as deputy group leader. Operating under both the Department of Cancer Research (DoCR) and the Department of Precision Health (DoPH), BraINE will benefit from the complementary experience of both departments in brain research. The group’s research activities, supported by recently awarded FNR and FNRS grants, include projects in medical imaging using AI foundation models and innovative technologies for precision brain health.  

BraINE represents a crucial step in advancing our understanding of brain health, and we look forward to seeing its impact

said Dr. Johannes Meiser, Director of the DoCR, and Dr. Guy Fagherazzi, Director of the DoPH, in a joint statement.

With this integration, the LIH reinforces its commitment to cutting-edge research in brain imaging and epidemiology, paving the way for groundbreaking discoveries in neurological health.